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STRUCTURAL-FUNCTIONAL RELATIONSHIPS
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Relationship of systemic blood pressure to nephropathology in insulin-
dependent diabetes mellitus. Although hypertension is an important
complication of diabetes it is unclear whether its association with other
diabetic complications represents cause or consequence. Our study is a
cross sectional evaluation of the relationship of blood pressure to renal
structural and functional parameters, in 139 patients with insulin
dependent diabetes for 18.9 7.4 years (mean SD), we divided the
patients into those with markedly increased mesangial volume fraction
[Vv(mes/glom) 0.371 and those with less Vv(mes/glom) < 0.371.
Hypertension (systolic BP  160 and/or diastolic BP > 90 mm Hg or
receiving BP medications) occurred in 29/40 with Vv(mes/glom)  0.37.
All 40 had clinical nephropathy with urinary albumin excretion (UAE)>
200 mg/24 hr. By two-way ANOVA creatinine clearance was lower and
albuminuria was increased with both hypertension and the expanded
mesangium. Also other measures of renal structure including filtration
surface, index of interstitial fibrosis and index of arteriolar hyalinosis
were increased by hypertension and mesangial expansion. Most pa-
tients with hypertension had other criteria for clinical nephropathy.
Since, in these studies, we could not determine if hypertension contrib-
uted to or resulted from the renal lesions, we developed an estimate of
the rate of mesangial expansion. We found that patients with normal BP
(119 11/78 7 mm Hg) can be rapidly developing mesangial
expansion. These studies support the view that the development of
serious renal lesions can be independent of hypertension in IDDM.
Further elucidation of the role of blood pressure in the genesis of
diabetic glomerulopathy will require longitudinal studies of both renal
structure and function in the first decade of IDDM.
An increased prevalence of hypertension has long been
recognized as an important complication of diabetes [1, 2].
More recently, studies have indicated that the presence of
hypertension in patients with overt nephropathy is associated
with a more rapid decline of glomerular filtration rate (GFR) [31,
and that effective treatment of hypertension is associated with a
marked slowing of the rate of decline of GFR [41. Further,
evidence is emerging indicating that antihypertensive treatment
can reduce urinary albumin excretion (UAE) and, perhaps,
impede the development of clinically apparent proteinuria in
insulin-dependent diabetes mellitus (IDDM) patients with "in-
cipient nephropathy" who do not yet have clearcut hyperten-
sion by World Health Organization Standards (>160/95mm Hg)
[51. These data support the concept that elevated systemic
blood pressure is an important determinant of progression of
established diabetic renal injury. Less is known regarding the
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role of systemic blood pressure in the genesis of the lesions of
diabetic nephropathy. Longitudinal studies of Pima Indians
with non-insulin-dependent diabetes mellitus (NIDDM) suggest
that hypertension is a significant risk factor for the later
development of clinical renal disease [6]. However, it is uncer-
tain as to whether the nephropathy developing in these patients
represents an acceleration of diabetic nephropathology, a sum-
mation of diabetic and hypertensive renal lesions or, whether
like proteinuria [71, hypertension in NIDDM patients may be an
indicator of the presence of a nondiabetic renal disease. Re-
cently, two studies have suggested that parental hypertension is
more common in IDDM patients with nephropathy compared to
patients without nephropathy [8, 9]. Further, both studies
suggested that the incidence of elevated red blood cell Na41LF4
countertransport activity, a putative genetic marker for essen-
tial hypertension, was increased in IDDM patients with
nephropathy as compared to those without nephropathy [8, 9].
The investigators argued that the background of essential
hypertension could be a risk factor for the development of
nephropathy in IDDM patients. However, studies from Den-
mark failed to confirm greater incidences of hypertension or
increased red blood cell Na/Li countertransport activity in
IDDM parents of patients with nephropathy compared to those
without nephropathy [101. IDDM patients, whether or not they
had nephropathy, had higher Na/Li countertransport activity
than nondiabetic subjects. In these studies IDDM patients with
nephropathy had higher levels than IDDM patients without
nephropathy [10]. Thus, the role of systemic blood pressure in
the pathogenesis of diabetic nephropathy remains unclear. This
report details a cross sectional study of the relationship of
systemic blood pressure to the renal lesions of diabetes in a
large group of IDDM patients.
Methods
Patients
These studies included 139 patients, 46 male and 93 female,
ages 9 to 55 years (30.5 7.4 years, mean SD) who had IDDM
for 1 to 40 years (18.9 7.4 years) whose age of onset was from
ito 32 years (11.2 7.3 years). The current cohort contains 65
patients previously described in other reports [11—13]. One
hundred and thirty-five patients had renal biopsies performed as
part of their evaluation as potential pancreas transplant recipi-
ents. Four patients had renal biopsies because of minimal
proteinuria or hypertension developing between 5 and 11.5
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years after the onset of IDDM (2 patients) or as baseline
biopsies for the institution of strict glycemic control (2 pa-
tients). Since almost all these patients were being elevated for
pancreas transplant, it is possible that this group may have had
a higher incidence of serious complications of diabetes than the
general population of IDDM patients. All potential pancreas
transplant recipients were studied according to a protocol
approved by the Committee on the Use of Human Subjects in
Research at the University of Minnesota. The patients were
studied in the Clinical Research Center at the University of
Minnesota Hospitals. All patients with adequate renal biopsy
tissue were included in this study.
Renal studies: Functional
Creatinine clearances (Cr) were determined by standard
laboratory procedures. At least two, and usually three, clear-
ance studies were performed on each patient before renal
biopsy, and the mean of these clearances, where necessary
corrected up to 1.73 m2, was calculated. Normal values for our
laboratory for creatinine clearance are at 95 to 115 mI/mm/I .73
m2. Cr ranged from above normal to 40 ml/min/l.73 m2. We
have previously demonstrated excellent correlations (r = 0.92)
between Cr and inulin clearances in IDDM patients in this
range of glomerular filtration (GFR) [12]. Twenty-four hour
urinary albumin excretion rate (UAE) was measured either by
nephelometry using the Beckman kit (Beckman Instruments,
Inc., Fullerton, California, USA) or by fluorometric immunoas-
say [13]. These two methods provide comparable results except
that the nephelometry method is imprecise in the normoalbu-
minuric range. Blood pressure data were expressed as the mean
of at least 10 repeated determinations performed over several
days. Blood pressure was measured by trained research nurses
in the Clinical Research Center. Criteria for the definition of
hypertension were taken from the Joint National Committee on
the Detection, Evaluation and Treatment of High Blood Pres-
sure [14] and the Task Force on Blood Pressure Control in
Children [151. None of the patients under age 18 in this study
had hypertension. Accordingly, for the adults in this study,
systolic blood pressure  160 mm Hg or diastolic blood
pressure  90 mm Hg, were defined as hypertension. Patients
receiving drug therapy for hypertension were classified as
hypertensive irregardless of their blood pressure measurements
obtained at the time of study. Borderline hypertension was
defined as systolic blood pressures 140 to 159 mm Hg or
diastolic blood pressures 85 to 89 mm Hg [14]. Only seven
patients had borderline hypertension. Measures of UAE, C,
and renal diabetic pathology were intermediate in these patients
between those with normal blood pressure (systolic BP < 140
mm Hg; diastolic < 85 mm Hg) and those with hypertension.
For all subsequent analyses the borderline hypertensive group
was included in the normal blood pressure category. The
presence or absence of hypertension but not the blood pressure
values were considered in patients receiving antihypertensive
drugs.
Morphologic studies
All patients had renal biopsies. Seven patients had needle
biopsies performed at the time of surgery for pancreas trans-
plantation. One hundred and thirty-two were percutaneous
renal biopsies accomplished with only two complications, an
inadvertent biopsy of a spleen and a temporary obstruction of
the bladder with blood clots requiring cystoscopic evacuation.
No surgical interventions or permanent sequelae resulted. The
biopsy specimens were immediately examined under a dissect-
ing microscope to insure adequacy of the sample and the
correct division of the core to provide glomeruli for light and
electron microscopy.
Light microscopy
Percent scierosed glomeruli. This parameter was determined
on Zenker-fixed paraffin embedded tissues using periodic acid-
Schiff (PAS) stained sections 2 tm apart, being careful not to
count the same glomeruli twice by studying sections at least 200
tm apart. Glomeruli were considered to have global sclerosis if
all of the glomerular tufts were, at the one extreme, totally
replaced by dense scar or, at the other extreme, were collapsed
and involuted as evidenced by wrinkling of the glomerular
basement membrane (GBM) and marked irregularity of the
capillary lumenal space. In previous studies we have shown
that correction of the percent of sclerotic glomeruli data for the
smaller volume of sclerotic compared to open glomeruli or
arcsine transformation of these data to minimize the influence
of sample size on this parameter did not change the statistical
results [16]. Thus, only the unmodified data are presented in
this report.
Glomerular volume. Mean glomerular volume was deter-
mined on light microscopic sections using the point counting
method of Hirose and co-workers [17].
Index of arteriolar hyalinosis. The index of arteriolar hyali-
nosis is the estimate of the degree of replacement of afferent and
efferent glomerular arteriolar smooth muscle by waxy homoge-
neous PAS-positive material. Incomplete replacement of a few
vessels was graded as 0.5, incomplete replacement of most
vessels as 1.5, complete replacement of approximately one-half
of the arterioles as 2.5, and complete replacement of most
vessels as 3.5 [11].
Index of interstitial fibrosis. The index of interstitial fibrosis
was determined as previously described as a semiquantitative
estimate of the space occupied by fibrous tissue separating
cortical tubules [11]; 0 was used as normal, 1.0 as twice normal
thickness, 2.0 as three times normal thickness, etc.
Electron microscopy
Part of the biopsy specimen was fixed in 2.5% glutaraldehyde
in 0.17 M cacodylate buffer and prepared for electron micros-
copy (EM) [11]. Adequate tissue for EM evaluation from these
biopsies was available in all patients. The stereologic EM
methods employed in these studies have been detailed else-
where [11, 12] and are briefly summarized here. At least three
different glomeruli from well preserved tissues were measured,
except in a few instances when only two glomeruli per biopsy
were available. To avoid selection bias, the centermost glomer-
ulus in each block was studied, unless glomeruli were found in
only one or two blocks.
Electron microscopic morphometric analysis was performed
as previously described in detail. GBM thickness was obtained
by the orthogonal intercept method described by Jensen et al
[18]. In normal subjects, based on 118 individuals aged 9 to 65
years, the GBM width was 349 49 nm [19].
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Table 1. Clinical characteristics of the study group according to the presence of hypertension and expansion of mesangium
Normotensives Hypertensives ANOVA
VvMes<37% VvMes37% VvMes<37% VvMes37%
N=72 N=1l N=27 N29 M H I
Study groups 1 2 3 4
Sex (M/F) 24/48 1/10 8/19 13/16
Age at exam 30 8 33 5 30 8 32 7 NS NS NS
Age at onset 12 7 12 5 9 6 12 5 NS NS NS
Duration of IDDM 18 8 20 4 20 8 20 5 NS NS NS
Level of glycemic control 10.1 2.2 10.6 2.6 10.3 1.5 11.2 2.3 NS NS NS
(HbAJ; %)
Systolic BP 116 10 121 6 124 12 132 13 <0.001 Not Done
Diastolic BP 75 7 7 4 81 8 85 8 <0.001 Not Done
Number receiving 0/72 0/11 26/27 28/29 — — —
antihypertensive
therapy
a Results of one-way or two-way ANOVA: effect of mesangium (M) or hypertension (H) or their interaction (I).
Fractional volumes of glomerular components were mea-
sured by point counting methods which determined the propor-
tion (or fractional volume) of points falling on a given compo-
nent of the glomerulus. The demarcations used to delineate the
mesangium were as previously described. The fractional vol-
umes of the total mesangium including its matrix and cellular
components were measured, excluding the glomerular base-
ment membrane lying between the epithelial cell and the
mesangium. The average volume fraction of total mesangium
(Vv mesangium) measured in this way in 118 normal subjects
was 0.14 0.04 with the matrix and cellular components each
averaging 0.07 0.02 [19].
The surface density of the peripheral glomerular basement
membrane (Sv PGBM) was measured by a grid using standard
stereologic techniques [11, 12]. The mean value for Sv(PGBM/
glom)in the 118 normal subjects was 0.13 0.02 [191. Capillary
filtering surface (surface/glomerulus) was determined from the
product of Sv(PGBM/glom) and glomerular volume [121.
Statistical methods
Patients were analyzed according to the presence or absence
of hypertension and the extent of mesangial expansion. Follow-
ing previous work [17] we utilized a Vv(mes/glom)  0,37 to
indicate marked expansion. Since all patients with Vv(mes/
glom)  0.37 have overt nephropathy and patients with lesser
lesions may or may not have overt nephropathy [111, patients
with Vv(mes/glom)  0.37 and < 0.37 were evaluated sepa-
rately. These two categories [blood pressure and Vv(mes/
glom)] were then utilized in a one-way or a two-way analysis of
variance (ANOVA) to determine their independent or interac-
tive effects upon other structural parameters of the renal
biopsy, measures of renal function and the basic demographic
information. When an interactive effect was observed, subse-
quent t-tests between groups were performed. A P value < 0.05
was considered significant. All values are expressed as mean
SD.
Results
Comparison of the demographic characteristics of the patient
population by two-way ANOVA revealed no significant differ-
ences in age of onset, age at study examination, duration of
IDDM, or glycemic control, Nor were there differences in male
to female ratios (Table 1). When normotensive and hyperten-
sive patients were compared by one-way ANOVA, patients
with Vv(mes/glom)  0.37 had higher systolic (P < 0.001) and
diastolic (P < 0.001) blood pressures (Table 1). For measures of
renal function analyzed by two-way ANOVA, creatinine clear-
ance was lower with a larger mesangium (P < 0.001) and with
hypertension (P = 0.004) with a possible interactive effect in
those patients with Vv(mes/glom) < 0.37. In this subgroup
those with hypertension had a lower Cr than normotensive
patients (85 29 vs. 112 29 ml/min/1.73 m2; P < 0.001 by
t-test). Albuminuria was increased with both hypertension and
the enlarged mesangium (Table 2).
By two-way ANOVA all other measures of renal structure
were influenced by Vv(mes/glom), and all, save GBM width and
percent glomerular sclerosis, by hypertension (Table 2). Inter-
action effects were seen for GBM width and filtration surface.
For GBM the interactive effect was related to the thinner GBM
width in those normotensive subjects with Vv(mes/glom) <0.37
compared to hypertensive subjects with Vv(mes/glom) < 0.37
(566 155 vs. 670 125 nm; P < 0.001 by t-test). Similarly, for
filtration surface those normotensive patients with Vv(mes/
glom) < 0.37 had a greater value than hypertensive patients
with Vv(mes/glom) <0.37 (0.14 0.06 vs. 0.11 0.03 m3 X
106, P < 0.01 by t-test).
Estimated rate of mesangial expansion and systemic blood
pressure
To determine whether patients with more rapid development
of mesangial expansion tended to have higher systemic blood
pressures, we categorized patients with Vv(mes/glom) < 0.37
into three groups. The "fast-track" normotensive group and
"fast-track" hypertensive group had Vv(mes/glom)  0.22 [that
is, above the upper range of normal for Vv(mes/glom) [1911 with
duration of IDDM  15 years. The "slow-track" group patients
had Vv(mes/glom) < 0.22 with duration of diabetes  20 years.
There were 8 "fast-track" normotensive, 11 "fast-track"
hypertensive, and 6 "slow-track" patients. Since most of the
"fast-track" hypertensive patients were receiving antihyper-
tensive medication and since most of these patients had overt
diabetic nephropathy by other criteria, it was considered im-
possible to evaluate the role of systemic blood pressure in the
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Table 2. Comparison of glomerular function and glomerular lesions in IDDM patients according to hypertension and mesangium expansion
Normotensives Hypertensives ANOVA
VvMes<37% VvMes37% VvMes<37%
N=72 N=ll N=27 N=29 M H I
Study groups 1 2 3 4
Creatinine clearance mi/mini 112 29 78 20 85 29 75 29 <0.001 0.004 NS
1.73 m2
UAE mg/24 hr 144 402 1137 911 536 683 1225 1060 0.04 0.03 NS
GBM width nm 566 150 776 113 670 125 750 136 <0.001 NS 0.03
Filtration surface /sm3 x 106 0.14 0.06 0.09 0.03 0.11 0.03 0.10 0.04 <0.001 0.04 0.04
Index of interstitial fibrosis % 1.0 0.8 2.1 0.7 1.7 0.9 2.3 1.0 <0.001 0.04 NS
Index of arteriolar hyalinosis 1.3 0.8 1.8 0.9 1.9 0.8 2.2 0.8 0.02 0.003 NS
Glomerular sclerosis % 8 12 22 15 11 13 20 17 <0.001 NS NS
a Results
of two-way ANOVA: effect of mesangium (M), or hypertension (H) or their interaction (I).
Table 3. Blood pressure (BP) values (mm Hg) in patients with Vv
mesangium <0.37 and normotension classified as "fast-track"
(duration <15 years and Vv mesangium 0.22) or "slow-track"
(duration 20 years and Vv mesangium <0.22)
Systolic BP Diastolic BP Mean BP
"Fast-track" 119 11(101—131) 78 7(68—87) 92 9(79—101)
normotensive
patients(N = 8)
"Slow-track" 121 8 (108—129) 79 6 (71—86) 93 6 (83—101)
patients(N =6)
Data are presented as mean standard (range).
genesis of diabetic nephropathy lesions in this group. Thus, the
"fast-track" normotensive and "slow-track" groups were com-
pared. Assuming a linear rate of mesangial expansion over time,
the estimated rate of mesangial expansion was determined by
the following formula: Vv(mes/glom) at biopsy — 0.14/duration
of IDDM in years [where 0.14 = mean value for Vv(mes/glom)
in normal adults]. Using this formula, the estimated rate of
mesangial expansion in the "fast-track" hypertensive patients
was 0.017 0.01 and in the "fast-track" normotensive patients
was 0.012 0.01 (NS). By selection, both were faster than that
of the "slow-track" patients, 0.001 0.001. The systolic,
diastolic, and mean blood pressures were nearly identical in the
"fast-track" normotensive and "slow-track" groups (Table 3),
Discussion
This study was undertaken to better understand the relation-
ship of systemic blood pressure to the development of the
lesions of diabetic nephropathy. It is known that the large
majority of patients with clinical diabetic nephropathy defined
by the presence of overt proteinuria will eventually develop
hypertension [2]. However, our cross sectional studies indicate
that some patients without overt nephropathy as defined by
dipstick positive proteinuria may have advanced renal lesions
associated with reduced GFR and hypertension [12, 201. Thus,
in patients with overt nephropathy it is impossible to determine
whether the hypertension contributed to the genesis of the renal
lesions or resulted from these advanced structural alterations.
Treatment of these patients with antihypertensive medications
slows the rate of decline of GFR [4], but it is unclear whether
this reduces the rate of progression of established specific
lesions of diabetic nephropathy lesions or represents an ame-
lioration of the nonspecific accelerating effect of systemic
hypertension on the progression of chronic renal injury of
whatever cause [21]. Antihypertensive treatment also reduces
UAE in IDDM patients with microalbuminuria [5]. However,
patients with microalbuminuria in the range which most inves-
tigators find highly predictive of later development of overt
proteinuria is also frequently associated with hypertension,
reduced GFR or both [22] and with well established lesions of
diabetic nephropathy [20].
The present study represents a cross sectional analysis of a
large group of IDDM patients with a broad spectrum of renal
disease ranging from normal structure and function to patients
with advanced renal lesions and established clinical nephrop-
athy with proteinuria, hypertension and GFR as low as 40
ml/min/l.73 m2. Although these patients may not be repre-
sentative of the general population of IDDM patients, there is
no reason to question the validity of the interrelationship of
structure and function presented here.
The criteria used for the definition of hypertension are
appropriate to the subjects in this study [14, 15]. The placement
of the patients with borderline hypertension (systolic BP 140 to
159 mm Hg; diastolic 85 to 89 mm Hg) [14] in the normotensive
group does not imply that we consider such levels of systemic
blood pressure to be normal or of no pathophysiologic signifi-
cance in diabetic patients. Rather, this was done so as to bias
against the thesis that hypertension in IDDM patients could be
largely the consequence of underlying renal lesions.
It is clear that the majority of diabetic patients with estab-
lished clinical nephropathy have hypertension. However, our
data suggest that systemic hypertension is not necessary in
order for the emergence of the advanced lesions of diabetic
nephropathy. Second, the nephropathic lesions of diabetes are
not, alone, a sufficient cause of the hypertension. Thus other
predisposing variables, perhaps relating to diet, humoral or
vascular responsiveness, are probably also involved in the
genesis of hypertension in IDDM patients with nephropathy
and GFR  40 ml/min/l.73 m2.
We compared glomerular function and structure in those with
and without hypertension among patients with less advanced
glomerular lesions [Vv(mes/glom) < 0.37J. Those with hyper-
tension had reduced GFR and increased UAE compared to
those with normal blood pressure, and most had achieved
additional clinical criteria for the diagnosis of overt nephrop-
athy. Furthermore, the hypertensive patients had more severe
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glomerular, vascular and interstitial lesions than the normoten-
sive patients except for GBM width and percent of glornerular
sclerosis. It was, therefore, not possible to deduce from these
cross sectional studies whether systemic hypertension acceler-
ated the development of diabetic glornerulopathy lesions or
whether the hypertension developed as a consequence of the
glomerular pathology. Since patients with the most rapid rates
of mesangial expansion had features of clinical nephropathy
after only 10 to 15 years of IDDM, it follows that longitudinal
studies must be initiated in the first decade of IDDM in order to
definitively sort out whether systemic blood pressure is a
significant variable in the rate of development of diabetic
nephropathy lesions or whether, in most instances, elevation in
blood pressure results from already established glomerular
pathology. In support of the latter hypothesis, there was no
significant difference in the estimated rate of development of
mesangial expansion in normotensive compared to hyperten-
sive patients in the "fast-track". Further, there was no ten-
dency for the blood pressure to be higher in normotensive
"fast-track" patients compared to "slow-track" patients. Our
results are also compatible with the thesis that systemic hyper-
tension is not necessary for patients to be rapidly developing
the critical lesions of diabetic nephropathy. These results are
compatible with those of Norgaard et a! [2], who found that the
increased prevalence of hypertension in IDDM patients was
occurring in patients with incipient and clinical nephropathy.
These authors concluded that this excess prevalence was the
result rather than the cause of diabetes nephropathy [2].
Mathiesen et al had similar conclusions from a prospective
study which suggested that blood pressure was similar in IDDM
patients at the onset of persistent microalbuminuria compared
with those whose UAE remained normal [23]. These investiga-
tors found that increasing blood pressures only became mani-
fest in the microalbuminuria patients one to two years after
increased UAE was first detected [231.
We conclude that severe diabetic nephropathy lesions are
usually but not inevitably associated with systemic hyperten-
sion. Hypertensive IDDM patients tend to have other func-
tional manifestations of diabetic nephropathy and severe renal
lesions. Lesions of diabetic nephropathy can be rapidly devel-
oping in patients with normal blood pressures. More precise
elucidation of the role of systemic blood pressure in the genesis
of diabetic nephropathology in IDDM requires prospective
studies to be initiated in the first decade of diabetes.
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